Effect of Modified Mesh on Surgical Success in Transobturator Tape Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorIzzet Celegen
About this trial
This study is a single-blind, randomized controlled trial evaluating whether changing the width of the surgical tape (mesh) used in transobturator tape (TOT) surgery improves treatment results in women with stress urinary incontinence (SUI). Two mesh widths are being compared: a 1.2 cm mesh (new method) and a 1.0 cm mesh (standard method). The main goal is to find out if the wider mesh leads to better urinary control and fewer complications. Participants will be followed for one year to measure cure rates, symptom improvement, and satisfaction.
Eligibility criteria
Qualifiers
Female patients aged 18 years or older
Positive stress test (urine leakage on coughing with a comfortably full bladder)
Q-tip test showing urethral hypermobility (>30 degrees)
Inadequate response to conservative therapy (e.g., pelvic floor muscle training, behavioral therapy)
Disqualifiers
History of prior midurethral sling surgery
Mixed urinary incontinence or urge-dominant symptoms
Pelvic organ prolapse stage > II according to the POP-Q system
Neurological disorders affecting bladder function (e.g., multiple sclerosis, spinal cord injury)
Trial design
Treatments tested in this trial
- 1.2 cm Mesh TOT
- 1.0 cm Mesh TOT
Treatment groups
106 Participants
are divided into 2 treatment groupsSponsors and collaborators
Izzet Celegen
Lead sponsor
Yuzuncu Yil University
Sponsor institution
Source ClinicalTrials.gov